We’re proud to once again be ranked in the top five of Americas Most Just companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help create a healthier world for all.
In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.
Lauren Huffmaster received a late-stage metastatic breast cancer (mBC) diagnosis in 2015 and soon discovered there wasn’t a lot information to help explain to her young children what she was going through.
Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we’ll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.
As a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals.
Kelly was getting ready to leave on a trip to celebrate her 25th wedding anniversary when she started experiencing pain in her abdomen and discovered a lump on her neck.
“For me, meeting my peers, women who were living with HIV and who also had children – that was a turning point for me,” Angelina says. “I needed that kind of support. It really helped me to cope back then.”
Gilead Sciences, Inc. (Nasdaq: GILD) today announced a new health equity collaboration with the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine and the Center for
We connected with Jared Baeten, Gilead’s Vice President of HIV Clinical Development to discuss the top highlights from AIDS 2022, and ways the company is looking to help transform care and improve outcomes for people affected by HIV.
Pharma’s reputation may have soared amid the pandemic, but that came with a brighter spotlight on diversity, equity and inclusion issues. In recent years, pharma has been trying to incorporate DEI more deeply into its corporate psyche.
The goal of the hackathon was to identify innovative, digital solutions to help improve PrEP education, access and care services, particularly for the Black and Hispanic/Latinx communities in the Southern United States.
In the corporate partnership landscape, GenderCool is increasing awareness of trans issues through its reverse mentorship program, where a champion is paired with a company for eight weeks.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...